Cargando…
The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation
Many polyphenolic compounds have been reported to inhibit protein kinases, with special reference to CK2, a pleiotropic serine/threonine kinase, implicated in neoplasia, neurodegenerative disease, and viral infections. In general however these compounds are not endowed with stringent selectivity. Am...
Autores principales: | Cozza, Giorgio, Venerando, Andrea, Sarno, Stefania, Pinna, Lorenzo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628998/ https://www.ncbi.nlm.nih.gov/pubmed/26558278 http://dx.doi.org/10.1155/2015/734127 |
Ejemplares similares
-
Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines
por: Li, Ke, et al.
Publicado: (2019) -
Detection of Phospho-Sites Generated by Protein Kinase CK2 in CFTR: Mechanistic Aspects of Thr1471 Phosphorylation
por: Venerando, Andrea, et al.
Publicado: (2013) -
The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131
por: Vilardell, Jordi, et al.
Publicado: (2018) -
The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design
por: Cozza, Giorgio
Publicado: (2017) -
Editorial: Casein kinases in human diseases
por: Venerando, Andrea, et al.
Publicado: (2022)